Symbol="ACOR"
AssetType="Common Stock"
Name="Acorda Therapeutics Inc"
Description="Acorda Therapeutics, Inc., a biopharmaceutical company, develops and markets therapies for neurological disorders in the United States. The company is headquartered in Ardsley, New York."
CIK="1008848"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="420 SAW MILL RIVER ROAD, ARDSLEY, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="16495000"
EBITDA="9540000"
PERatio="1.409"
PEGRatio="0.51"
BookValue="54.64"
DividendPerShare="0"
DividendYield="0"
EPS="9.03"
RevenuePerShareTTM="94.26"
ProfitMargin="-0.179"
OperatingMarginTTM="-0.188"
ReturnOnAssetsTTM="-0.0357"
ReturnOnEquityTTM="-0.269"
RevenueTTM="116914000"
GrossProfitTTM="82430000"
DilutedEPSTTM="9.03"
QuarterlyEarningsGrowthYOY="5.87"
QuarterlyRevenueGrowthYOY="-0.044"
AnalystTargetPrice="10"
TrailingPE="1.409"
ForwardPE="-"
PriceToSalesRatioTTM="0.108"
PriceToBookRatio="0.168"
EVToRevenue="1.497"
EVToEBITDA="-14.7"
Beta="1.432"
num_52WeekHigh="24.8"
num_52WeekLow="5.22"
num_50DayMovingAverage="14.95"
num_200DayMovingAverage="14.12"
SharesOutstanding="1242100"
DividendDate="2021-01-04"
ExDividendDate="None"
symbol="ACOR"
open="11.34"
high="12.35"
low="11.33"
price="11.55"
volume="5790.00"
latest_trading_day="2023-08-30"
previous_close="12.72"
change="-1.17"
change_percent="-9.1722%"
aroon_positive_momentum_days="73"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="73"
Volume_recent_avg="530564"
Change_recent_avg="0.14"
Delta_recent_avg="0.77"
Variance_recent_avg="0.38"
Change_ratio_recent_avg="0.91"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="73"
Aroon_momentum_negative="27"
image_negative_thumbnail_id_1="507"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0098.jpeg"
image_negative_thumbnail_id_2="152"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0024.jpeg"
image_neutral_thumbnail_id_1="573"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0026.jpeg"
image_neutral_thumbnail_id_2="591"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0008.jpeg"
image_positive_thumbnail_id_1="667"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0041.jpeg"
image_positive_thumbnail_id_2="600"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0108.jpeg"
image_professor_thumbnail_id_1="1187"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0021.jpeg"
image_professor_thumbnail_id_2="1197"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0031.jpeg"
